ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Short-term Debt

Borrowings and the current portion of long-term debt due within one year.

No reported Short-term Debt figures are available to summarize.

Short-term Debt history

Currency unavailable · from the balance sheet

No Short-term Debt data reported for this period type.

Short-term Debt vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Short-term Debt for ADRX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MGTXMeiraGTx Holdings plcMar 2026$27.13M USD——11.1%
PRQRProQR Therapeutics N.V.Mar 2026€4.62M EUR-1.9%+21.1%4.7%
RNAAtrium Therapeutics, Inc.Mar 2026$2.68M USD——0.9%
STOKStoke Therapeutics, Inc.Mar 2026$2.43M USD——0.5%
SLNSilence Therapeutics plcMar 2026$0 USD——0.0%
PRMEPrime Medicine, Inc.Mar 2026$0 USD——0.0%
WVEWave Life Sciences Ltd.Mar 2026$0 USD——0.0%
BNTCBenitec Biopharma Inc.Mar 2026$0 USD——0.0%
ARCTArcturus Therapeutics Holdings Inc.Mar 2026$0 USD——0.0%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-1.9%+21.1%0.0%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.